Alerts

Last year, we reported that Nebraska senators introduced the Agriculture Data Privacy Act (LB525), a first-of-its-kind privacy bill specifically aimed at regulating agricultural-sector data.

Mail and telemedicine access to mifepristone — used together with misoprostol to end an early pregnancy — is in flux following a Fifth Circuit Court of Appeals ruling that restricts mail-order distribution of the medication nationwide, and the US Supreme Court’s subsequent administrative stay restoring the status quo ante on a temporary basis.

In the latest episode of Five Questions, Five Answers, host Birgit Matthiesen is joined by ArentFox Schiff colleagues Jackson David Toof and Mario A. Torrico for a conversation on the False Claims Act (FCA), its origins, and its continued importance as a tool to combat fraud against the federal government.

On April 24, the US Attorney’s Office for the Eastern District of Tennessee announced a $2.1 million settlement with Echelon Fitness Multimedia, LLC, resolving False Claims Act (FCA) allegations of undervaluation leading to the underpayment of duties.

In a recent win for renewable energy developers, the Michigan Court of Appeals confirmed that Michigan law prohibits local governments from imposing requirements on wind, solar, and energy storage projects more restrictive than state law.

On December 22, the Internal Revenue Service (IRS) announced proposed updates to its Criminal Investigation Voluntary Disclosure Practice (VDP), opening a 90-day public comment period that closed on March 22. Revised procedures are expected to take effect six months after the changes are finalized.

On May 1, the US Food and Drug Administration (FDA) announced that it is proposing to exclude semaglutide, tirzepatide, and liraglutide from the 503B Bulks List. If finalized, this proposal would close the last remaining regulatory pathway for large-scale compounding of these popular GLP-1 receptor agonists by 503B outsourcing facilities.

Following recent episodes that examined specific US tariff announcements, today’s discussion takes a wider view.

On May 7, the US Court of International Trade (CIT) ruled 2-1 that the 10% tariffs President Trump imposed on virtually all US imports under Section 122 of the Trade Act of 1974 are unlawful.

On April 24, Taylor Swift’s company, TAS Rights Management, filed three new trademark applications with the US Patent and Trademark Office (USPTO) in what appears to be an effort to safeguard her identity against the rising threat of artificial intelligence (AI)-generated content. Two of the applications fall into the relatively uncommon category of “sound marks.”

Headlines that Matter for Companies and Executives in Regulated Industries

The US Patent and Trademark Office (USPTO) has extended and modified the Fast-Track Appeals Pilot Program, which allows appellants to have eligible ex parte appeals before the Patent Trial and Appeal Board (PTAB) advanced out of turn.

Nasdaq has significantly raised the financial bar for special purpose acquisition company (SPAC) listings. Effective May 15, the minimum market value listing threshold increases to $100 million on the Global Market and $75 million on the Capital Market, with stricter shareholder requirements on both tiers.

The saga of Joe Exotic has generated no shortage of legal drama. And a recent Tenth Circuit decision adds an important new chapter — one with significant implications for copyright holders and content creators alike across the entertainment industry.

Virginia is the latest jurisdiction to enact legislation broadening restrictions on the use of noncompete agreements.

The US Securities and Exchange Commission (SEC) has proposed amendments that would allow public companies to file semiannual reports in lieu of quarterly reports, marking a significant shift in the longstanding interim reporting framework under the federal securities laws. If adopted, companies would have the flexibility to file one semiannual report and one annual report each fiscal year, instead of three quarterly reports and one annual report.

On April 6, the US Department of the Treasury and the Internal Revenue Service (IRS) published Revenue Procedure 2026-14 (Designation Guidance) to provide guidance for the nomination of census tracts to be designated as qualified opportunity zones (OZs) under the now-permanent OZ regime under §§ 1400Z-1 and 1400Z-2 of the Internal Revenue Code, as amended by § 70421 of Public Law 119-21, 139 Stat. 72, 223 (July 4, 2025), commonly known as the One, Big, Beautiful Bill Act (OBBBA).

Data centers have a global reach, but their development is increasingly shaped by local land use decisions, public opinion, and evolving legislative frameworks. Across the country, state and local governments are introducing moratoria, revising zoning codes, and responding to community concerns in ways that directly affect project timelines and siting strategies.

Prop 65 Counsel: What To Know

The next phase of the Trump Administration’s efforts to end unlawful diversity, equity, and inclusion (DEI) practices moves forward with the issuance of new Federal Acquisition Regulation (FAR) clause 52.222-90.

On April 20, the US Supreme Court granted certiorari in Beaird v. United States, No. 25-5343, agreeing to decide whether its 1993 decision in Stinson v. United States, 508 US 36 (1993), still correctly defines how much deference federal courts owe the official commentary accompanying the US Sentencing Guidelines. The outcome could reshape how federal judges calculate sentencing ranges nationwide.

Headlines that Matter for Companies and Executives in Regulated Industries

On April 23, Acting Attorney General Todd Blanche announced a final order reclassifying US Food and Drug Administration (FDA)-approved drug products containing “marijuana” and cannabis products regulated under qualifying state-issued medical marijuana licenses from Schedule I to Schedule III of the Controlled Substances Act (CSA), effective April 28. Critically, adult-use (recreational) cannabis remains in Schedule I.

On April 22, Virginia enacted a new paid family and medical leave (PFML) insurance program after Governor Abigail Spanberger’s proposed amendments to Senate Bill 2 and House Bill 1207 were adopted by the General Assembly.

Everyone is talking about peptides. Your doctor, your trainer, that guy at the dinner party who swears that BPC-157 rebuilt his knee — peptides have officially entered the zeitgeist. But for every breathless testimonial, there is a thicket of regulations that most market participants barely understand.